AQST
AQST
NASDAQ · Pharmaceuticals

Aquestive Therapeutics Inc

$3.94
+0.02 (+0.51%)
As of Aug 8, 10:21 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +557.4% upside
Low Target $17.61
Average Target $25.90
High Target $34.98
Current Price $3.94
Current
$3.94
Target
$25.90
$17.61 $25.90 avg $34.98
Scenario Analysis
Bear Case
$17.61
347.0%
Low target
Base Case
$25.90
+557.4%
Avg target
Bull Case
$34.98
+787.8%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$7.55
-47.8% from high
52-Week Low
$2.93
+34.5% from low
Target vs 52W High
$25.90
+243.0% vs high
Next Earnings Report
Aug 11, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.11
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%